Khaled Hamden

3.5k total citations
79 papers, 2.7k citations indexed

About

Khaled Hamden is a scholar working on Endocrinology, Diabetes and Metabolism, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Khaled Hamden has authored 79 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Organic Chemistry and 16 papers in Molecular Biology. Recurrent topics in Khaled Hamden's work include Natural Antidiabetic Agents Studies (24 papers), Diet, Metabolism, and Disease (20 papers) and Phytochemicals and Antioxidant Activities (9 papers). Khaled Hamden is often cited by papers focused on Natural Antidiabetic Agents Studies (24 papers), Diet, Metabolism, and Disease (20 papers) and Phytochemicals and Antioxidant Activities (9 papers). Khaled Hamden collaborates with scholars based in Tunisia, France and Saudi Arabia. Khaled Hamden's co-authors include Abdelfattah Elfeki, Abdelfattah El Feki, Serge Carreau, Noureddine Allouche, Bassem Jaouadi, Fatma Ayadi, Kais Mnafgui, Hatem Masmoudi, Mohamed Damak and Mohamed Ali Boujbiha and has published in prestigious journals such as The Journal of Organic Chemistry, Molecules and RSC Advances.

In The Last Decade

Khaled Hamden

77 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled Hamden Tunisia 34 766 685 449 439 382 79 2.7k
Abdelfattah Elfeki Tunisia 32 554 0.7× 618 0.9× 302 0.7× 644 1.5× 467 1.2× 99 2.7k
Anand Kar India 31 873 1.1× 644 0.9× 451 1.0× 953 2.2× 274 0.7× 122 3.2k
Hamadi Fetoui Tunisia 36 390 0.5× 693 1.0× 475 1.1× 1.0k 2.4× 443 1.2× 98 3.3k
Hideo Satsu Japan 29 332 0.4× 1.0k 1.5× 404 0.9× 244 0.6× 241 0.6× 90 2.9k
Stephen Adeniyi Adefegha Nigeria 31 930 1.2× 623 0.9× 471 1.0× 923 2.1× 596 1.6× 127 3.1k
Oluwatosin A. Adaramoye Nigeria 31 480 0.6× 541 0.8× 299 0.7× 690 1.6× 151 0.4× 107 2.4k
Patchareewan Pannangpetch Thailand 26 405 0.5× 635 0.9× 247 0.6× 379 0.9× 140 0.4× 56 2.0k
Saeideh Momtaz Iran 29 284 0.4× 911 1.3× 292 0.7× 490 1.1× 386 1.0× 105 3.0k
Oluwafemi Adeleke Ojo Nigeria 26 556 0.7× 701 1.0× 194 0.4× 605 1.4× 214 0.6× 204 2.6k
Jean‐Max Rouanet France 31 303 0.4× 556 0.8× 478 1.1× 397 0.9× 353 0.9× 53 2.7k

Countries citing papers authored by Khaled Hamden

Since Specialization
Citations

This map shows the geographic impact of Khaled Hamden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Hamden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Hamden more than expected).

Fields of papers citing papers by Khaled Hamden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Hamden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Hamden. The network helps show where Khaled Hamden may publish in the future.

Co-authorship network of co-authors of Khaled Hamden

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Hamden. A scholar is included among the top collaborators of Khaled Hamden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Hamden. Khaled Hamden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
El-Sofany, Walaa I., Ismail Daoud, Salman Latif, et al.. (2025). Novel triazole-tethered thiazol-4(5H)-one hybrids as potential therapeutics for obesity and type 2 diabetes: in vitro, in vivo, and in silico evaluations. Journal of Molecular Structure. 1341. 142577–142577.
3.
4.
5.
Hamden, Khaled, et al.. (2023). Design, synthesis and biological evaluation of new 1,ω-Bis-(5-alkyl-3-tosyl-1,3,4,2-triazaphospholino)alkanes as in vitro α-amylase and lipase inhibitors. International Journal of Biological Macromolecules. 253(Pt 5). 127195–127195. 1 indexed citations
6.
Al-Shaikh, Turki M., et al.. (2023). Betalain-Enriched Beetroots Exhibit Antiulcer and Anti-inflammatory Potentials. Journal of Food Processing and Preservation. 2023. 1–11. 16 indexed citations
7.
Amri, Zahra, et al.. (2023). The Use of D-Optimal Mixture Design in Optimizing Formulation of a Nutraceutical Hard Candy. International Journal of Food Science. 2023. 1–12. 6 indexed citations
8.
Hamden, Khaled, et al.. (2018). Inhibitory Effect of fermented pectin on key metabolic enzymes associated with diabetes, obesity; and Liver-Kidney tissues toxicities. Bioactive Carbohydrates and Dietary Fibre. 16. 82–89. 9 indexed citations
9.
Hamden, Khaled, et al.. (2018). Phytoestrogens inhibit key-enzymes linked to obesity, type 2 diabetes and liver-kidney toxicity in high fructose-fat diet in mice. Archives of Physiology and Biochemistry. 125(5). 423–429. 9 indexed citations
10.
Trabelsi, Imen, Naourez Ktari, Sirine Ben Slima, Khaled Hamden, & Riadh Ben Salah. (2016). Effect of a probiotic Lactobacillus plantarum TN8 strain on trinitrobenzene sulphonic acid‐induced colitis in rats. Journal of Animal Physiology and Animal Nutrition. 101(2). 311–319. 8 indexed citations
11.
Hamden, Khaled, et al.. (2015). Synthesis and Evaluation of New Bis‐1,3,4,2‐triazaphospholinoalkane Derivatives as In Vitro α‐Amylase and Lipase Inhibitors. Archiv der Pharmazie. 348(3). 188–193. 6 indexed citations
12.
Zouari, Raida, Rihab Ben Abdallah Kolsi, Khaled Hamden, et al.. (2015). Assessment of the antidiabetic and antilipidemic properties of bacillus subtilis spb1 biosurfactant in alloxan‐induced diabetic rats. Biopolymers. 104(6). 764–774. 36 indexed citations
13.
Hamden, Khaled, et al.. (2013). Synthesis and Evaluation of 1,ω‐Bis(1,2,3,5‐thiatriazol‐5‐yl)alkanes as In Vitro and In Vivo α‐Amylase and Lipase Inhibitors. Archiv der Pharmazie. 346(4). 321–329. 4 indexed citations
14.
15.
Mnafgui, Kais, et al.. (2013). Inhibition of key enzymes related to diabetes and hypertension by Eugenol in vitro and in alloxan-induced diabetic rats. Archives of Physiology and Biochemistry. 119(5). 225–233. 63 indexed citations
16.
Gargouri, Bochra, et al.. (2011). Hydroxytyrosol supplementation inhibits oxidative DNA damage, suppresses protein-lipid oxidation and modulates antioxidant enzymes in human peripheral blood lymphocytes. Journal of Medicinal Plants Research. 5(19). 4863–4869. 6 indexed citations
17.
Hamden, Khaled, et al.. (2010). Inhibitory effects of estrogens on digestive enzymes, insulin deficiency, and pancreas toxicity in diabetic rats. Journal of Physiology and Biochemistry. 67(1). 121–128. 25 indexed citations
18.
Hamden, Khaled, et al.. (2009). Inhibitory action of hydroxytyrosol from glucose-induced Insulin deficient and pancreas and liver toxicity in vitro. Current Trends in Biotechnology and Pharmacy. 3(4). 352–361. 6 indexed citations
19.
Soussi, Ahlem, et al.. (2009). Oral administration of Eucalyptus globulus extract reduces the alloxan-induced oxidative stress in rats. Chemico-Biological Interactions. 181(1). 71–76. 39 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdelfattah Elfeki Breakdown of academic impact, for papers by Anand Kar Breakdown of academic impact, for papers by Hamadi Fetoui Breakdown of academic impact, for papers by Hideo Satsu Breakdown of academic impact, for papers by Stephen Adeniyi Adefegha Breakdown of academic impact, for papers by Oluwatosin A. Adaramoye Breakdown of academic impact, for papers by Patchareewan Pannangpetch Breakdown of academic impact, for papers by Saeideh Momtaz Breakdown of academic impact, for papers by Oluwafemi Adeleke Ojo Breakdown of academic impact, for papers by Jean‐Max Rouanet
Rankless by CCL
2026